UL
Ultragenyx
🇩🇪XFRA.UP0GermanyHealthcare
€11.26EURdown -0.49 (-4.17%)OpenEnd of day2:55 PM
Price€11.26-0.49 (-4.17%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US90400D1081
- CUSIP
- Not reported
Company
- Employees
- 1,371
- Headquarters
- Novato, United States
- Website
- https://www.ultragenyx.com
- CEO
- Dr. Emil D. Kakkis M.D., Ph.D.
Market
- Shares outstanding
- 98.6M
- Market cap
- €1.11B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
No high and low reported for today's session.
- Market cap
- €1.11B
- EPS LTM
- -$5.75
- P/E LTM
- -5.80
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $716.93M+17.5%up year on year
- Net income
- -$586.41M-10.04%down year on year
- Gross margin
- 83.12%-2.57%down year on year
- Free cash flow
- -$489.47M-14.55%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.